2001Journa of Henan Medical UniversityRequires access

Relative bioavailability and pharmacokinetics of azithromycin in healthy volunteers

MA Tongxun

Open publisher page 0 citations

Abstract

Aim: To study the pharmacokinetics and relative bioavailability of azithromycin in healthy volunteers. Methods: The serum concentraions of azithromycin of two formulations were determined in 8 healthy male volunteers after an oral dose of 1000 mg azithromycin granules or capsules in crossways. The serum and urine samples were collected at various periods after oral administration. The serum and urine concentrations of azithromycin were determined by microbiological method. Results: The concentration time curves of azithromycin granules and capsules were fitted to the two compartment open model. The C max values were (1.77±0.42)mg/L and (1.78±0.63) mg/L,the T\- max values were (1.88±0.64) h and (1.88±0.35) h and the AUC were (16.69±3.20) mg·h·L -1 and (16.95±3.09) mg·h·L -1 , respectively. The relative bioavailability of granules to capsules were (101.97±10.46)%. Conclusion: It is suggested that the 2 formulations are bioequivalent.

About this research paper

What this paper is about

Aim: To study the pharmacokinetics and relative bioavailability of azithromycin in healthy volunteers. Methods: The serum concentraions of azithromycin of two formulations were determined in 8 healthy male volunteers after an oral dose of 1000 mg azithromycin granules or capsules in crossways. The serum and urine samples were collected at various periods after oral administration. The serum and urine concentrations of azithromycin were determined by microbiological method. Results: The concentration time curves of azithromycin granules and capsules were fitted to the two compartment open model. The C max values were (1.77±0.42)mg/L and (1.78±0.63) mg/L,the T\- max values were (1.88±0.64) h and (1.88±0.35) h and the AUC were (16.69±3.20) mg·h·L -1 and (16.95±3.09) mg·h·L -1 , respectively. The relative bioavailability of granules to capsules were (101.97±10.46)%. Conclusion: It is suggested that the 2 formulations are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Aim: To study the pharmacokinetics and relative bioavailability of azithromycin in healthy volunteers. Methods: The serum concentraions of azithromycin of two formulations were determined in 8 healthy male volunteers after an oral dose of 1000 mg azithromycin granules or capsules in crossways. The serum and urine samples were collected at various periods after oral administration. The serum and urine concentrations of azithromycin were determined by microbiological method. Results: The concentration time curves of azithromycin granules and capsules were fitted to the two compartment open model. The C max values were (1.77±0.42)mg/L and (1.78±0.63) mg/L,the T\- max values were (1.88±0.64) h and (1.88±0.35) h and the AUC were (16.69±3.20) mg·h·L -1 and (16.95±3.09) mg·h·L -1 , respectively. The relative bioavailability of granules to capsules were (101.97±10.46)%. Conclusion: It is suggested that the 2 formulations are bioequivalent.

Key concepts: Azithromycin, Bioavailability, Bioequivalence, Pharmacokinetics, Urine, Pharmacology, Medicine, Oral administration

Related papers

Back to paper searchBrowse research topicsOriginal source
Relative bioavailability and pharmacokinetics of azithromycin in healthy volunteers — Research Paper | ScholarLens